Anti-Malaria Drug Policy - Ghana Health Service
Anti-Malaria Drug Policy - Ghana Health Service
Anti-Malaria Drug Policy - Ghana Health Service
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ANTI-MALARIA DRUG POLICY FOR GHANA<br />
manufacture of monotherapies for the treatment of<br />
uncomplicated malaria shall not be allowed.<br />
6.3 Re-Classifying <strong>Anti</strong>-<strong>Malaria</strong> Combination<br />
Therapies<br />
Artemisinin based combination therapies are classified as<br />
'prescription only' drugs. This means that they have to be<br />
prescribed by a clinician and dispensed by a pharmacist.<br />
The recommended ACTs shall now be re-classified as Overthe-Counter<br />
(OTC) medicines permissible to be dispensed<br />
at all levels to ensure ready availability to the general<br />
public.<br />
6.4 Supply of <strong>Anti</strong>-malarials<br />
6.4.1 The Ministry of <strong>Health</strong> shall support the local<br />
pharmaceutical manufacturing industry to build capacity to<br />
meet internationally accepted requirements of Good<br />
Manufacturing Practices in the production of ACTs. This will<br />
facilitate sustainability of this policy especially the provision<br />
of facilities for conducting bioavailability and<br />
bioequivalence studies among others so as to enhance the<br />
manufacture and supply of the ACTs to both the public and<br />
the private sectors.<br />
MINISTRY OF HEALTH<br />
17
Change language